PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up
Abstract
Authors
S. Odes D. Greenberg H. Vardi M. Friger R. Stockbrugger P. Munkholm